|
시장보고서
상품코드
1807174
단백질 특성 분석 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품 및 서비스별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)Protein Characterization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Application, By End-Use, By Region and Competition, 2020-2030F |
||||||
세계의 단백질 특성 분석 시장 규모는 2024년에 154억 5,000만 달러로 평가되었고, 2030년에는 340억 7,000만 달러에 이를 것으로 예측되며, CAGR은 14.06%를 나타낼 전망입니다.
세계의 단백질 특성 분석 시장은 단백질체학가 중시되게 되어, 세포 기능이나 질병 메커니즘의 해명에 있어서 그 역할이 높아지고 있기 때문에 견조한 확대를 볼 수 있습니다. 중요한 바이오마커와 치료 표적인 단백질은 신약, 진단, 맞춤형 의료의 핵심입니다. 이러한 이유로 생명공학 및 제약 회사는 첨단 단백질 분석 기술에 대한 투자를 촉진하고 있습니다. 질량 분석, 크로마토그래피, 전기영동과 같은 도구는 단백질 구조, 번역 후 변형, 상호작용 연구에 널리 사용됩니다. 정밀의료 및 생물 제제에 대한 수요 증가는 정확한 단백질 프로파일링의 필요성을 더욱 가속화하고 있습니다. 생명 과학 연구에 대한 정부 보조금 증가와 학술 기관과 기업 간의 공동 연구의 활성화는 시장 확대를 지원합니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 154억 5,000만 달러 |
| 시장 규모 : 2030년 | 340억 7,000만 달러 |
| CAGR : 2025-2030년 | 14.06% |
| 급성장 부문 | 신약 개발 및 연구 |
| 최대 시장 | 북미 |
시장을 형성하는 동향은 단백질 분석에서 인공지능과 머신러닝의 통합을 포함하여 보다 신속한 데이터 처리 및 예측 모델링을 가능하게 합니다. 자동화 및 고처리량 스크리닝 기술은 분석 시간을 단축하고 재현성을 향상시켜 대규모 용도의 효율성을 향상시킵니다. 단백질체학와 유전체학 및 대사체학를 결합한 멀티오믹스 접근법의 출현은 생물학적 인사이트의 깊이를 높이고 종합적인 프로파일링을 촉진합니다. 소형화된 랩 칩 플랫폼은 특히 임상 진단에서 포인트 오브 케어 용도의 견인 역할을 하고 있습니다. 업계 각사는 원활한 데이터 통합, 해석, 시각화를 가능하게 하는 사용하기 쉬운 소프트웨어 툴의 개발에도 주력하고 있어 연구자의 발견을 가속화하고 있습니다.
생물제제 및 바이오시밀러 수요 증가
장비 및 분석 서비스의 높은 비용
단일클론항체 및 생물제제 개발 증가
Global Protein Characterization Market was valued at USD 15.45 Billion in 2024 and is expected to reach USD 34.07 Billion by 2030 with a CAGR of 14.06%. The Global Protein Characterization Market is witnessing robust expansion due to the growing emphasis on proteomics and its role in understanding cellular functions and disease mechanisms. Proteins, being key biomarkers and therapeutic targets, are central to drug discovery, diagnostics, and personalized medicine. This has prompted biotechnology and pharmaceutical companies to invest in advanced protein analysis technologies. Tools such as mass spectrometry, chromatography, and electrophoresis are widely used to study protein structure, post-translational modifications, and interactions. Increasing demand for precision medicine and biologics has further accelerated the need for accurate protein profiling. Rising government funding for life sciences research and an uptick in collaborations between academic institutions and industry players are supporting the market's expansion.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 15.45 Billion |
| Market Size 2030 | USD 34.07 Billion |
| CAGR 2025-2030 | 14.06% |
| Fastest Growing Segment | Drug Discovery & Development |
| Largest Market | North America |
Trends shaping the market include the integration of artificial intelligence and machine learning in protein analysis, enabling faster data processing and predictive modeling. Automation and high-throughput screening technologies are reducing analysis time and improving reproducibility, making protein characterization more efficient for large-scale applications. The emergence of multi-omics approaches, combining proteomics with genomics and metabolomics, is enhancing the depth of biological insights and encouraging comprehensive profiling. Miniaturized and lab-on-chip platforms are gaining traction for point-of-care applications, especially in clinical diagnostics. Industry players are also focusing on developing user-friendly software tools that allow seamless data integration, interpretation, and visualization, helping researchers accelerate discoveries.
Key Market Drivers
Rising Demand for Biologics and Biosimilars
The increasing demand for biologics and biosimilars is a significant driver for the Global Protein Characterization Market. Biologics, including monoclonal antibodies, therapeutic proteins, and vaccines, are revolutionizing the treatment of various diseases, particularly in oncology, autoimmune disorders, and genetic diseases. As these therapies continue to grow in importance, the need for precise and comprehensive protein characterization and identification becomes crucial. Protein characterization techniques allow for the analysis of protein structures, functions, and interactions, which is vital for ensuring the safety, efficacy, and quality of biologic drugs.
In 2023, the U.S. Food and Drug Administration (FDA) approved 55 new drugs, of which 17 were biologics, accounting for 30.9% of all drug approvals. Notably, 12 of these biologics were monoclonal antibodies, marking a significant milestone in biologic drug development. The Center for Biologics Evaluation and Research (CBER) added 23 new biologics license application approvals in 2023, highlighting the growing focus on biologic therapies.
Similarly, the European Medicines Agency (EMA) recommended 77 medicines for marketing authorization in 2023, with 39 having a new active substance. This indicates a strong emphasis on innovative therapies, including biologics, in the European market.
The increasing focus on biosimilars, which are similar to original biologic drugs but at a lower cost, further fuels the demand for protein characterization. As the patents of several blockbuster biologics expire, pharmaceutical companies are investing heavily in the development of biosimilars to tap into this growing market. Ensuring the structural and functional similarity of biosimilars to their reference biologics is critical, and this requires advanced protein characterization methods such as mass spectrometry, chromatography, and peptide mapping.
Regulatory agencies worldwide, including the FDA and EMA, have established rigorous guidelines to assess the quality and safety of biologics and biosimilars, which in turn drives the need for precise protein identification techniques. As biologic therapies gain popularity and the biosimilars market expands, the demand for protein characterization and identification solutions will continue to rise, accelerating market growth and innovation in this sector.
Key Market Challenges
High Cost of Instruments and Analytical Services
The high cost of instruments and analytical services remains a significant challenge for the Global Protein Characterization Market. Cutting-edge protein characterization tools such as mass spectrometers, chromatography systems, and protein analyzers are critical for accurate and reliable results. These advanced instruments often come with hefty price tags, making them unaffordable for smaller research institutions, universities, and laboratories, particularly in emerging markets. The expense associated with these technologies can create a barrier to entry for organizations with limited financial resources, thereby hindering widespread adoption of advanced protein characterization methods.
Beyond the high initial purchase cost, maintaining and operating these instruments requires specialized training, skilled personnel, and regular servicing, all of which add to the ongoing expenses. The need for highly trained technicians and scientists to operate these advanced technologies further drives up operational costs. Additionally, the reliance on specialized reagents and consumables for protein analysis can contribute to the overall expense. For many research entities, these financial constraints may limit the frequency of protein characterization studies and the scope of their research projects.
Key Market Trends
Rise in Monoclonal Antibody and Biologics Development
The rise in monoclonal antibody (mAb) and biologics development is significantly driving the Global Protein Characterization Market. With the growing emphasis on biologic therapies, including monoclonal antibodies, protein characterization and identification have become essential to ensuring the safety, efficacy, and consistency of these therapies. As biologics are increasingly utilized for treating chronic diseases, cancers, and autoimmune conditions, accurate protein analysis is vital to understanding their molecular structures, functionality, and therapeutic potential. This trend is particularly pronounced with the growing use of mAbs, which are highly complex molecules that require precise characterization for both drug development and regulatory approval.
The growing complexity of biologics has led to increased demand for advanced proteomics tools, such as mass spectrometry and chromatography, to analyze proteins and their interactions. This demand is expected to rise as the pharmaceutical industry focuses on personalized medicine, where the detailed profiling of proteins in the context of individual patients is crucial. Accurate protein identification is pivotal in the development of next-generation biologics, as even slight structural variations can impact the therapeutic outcome.
In this report, the Global Protein Characterization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Protein Characterization Market.
Global Protein Characterization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: